2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 15.365 | 20.840 | 37.662 | 39.313 | 34.836 | 29.470 | 15.144 | 14.162 | 16.961 | 14.725 |
Total Income - EUR | 15.365 | 20.840 | 37.662 | 39.313 | 34.836 | 29.470 | 15.144 | 14.162 | 17.570 | 19.577 |
Total Expenses - EUR | 15.183 | 21.883 | 30.452 | 34.905 | 28.981 | 22.340 | 10.287 | 11.093 | 13.870 | 19.487 |
Gross Profit/Loss - EUR | 182 | -1.044 | 7.211 | 4.408 | 5.855 | 7.130 | 4.857 | 3.069 | 3.700 | 90 |
Net Profit/Loss - EUR | -279 | -1.669 | 6.834 | 4.015 | 5.506 | 6.836 | 4.508 | 3.058 | 3.562 | -47 |
Employees | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Luxraniva Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 107 | 105 | 2.155 | 1.773 | 2.659 | 2.115 |
Current Assets | 28.132 | 27.723 | 32.961 | 31.178 | 35.547 | 36.926 | 29.690 | 29.461 | 29.630 | 27.267 |
Inventories | 27.834 | 27.681 | 31.445 | 29.222 | 27.677 | 27.307 | 25.611 | 23.560 | 22.274 | 21.749 |
Receivables | 0 | 0 | 0 | 0 | 1.511 | 0 | 46 | 110 | 4.012 | 1.748 |
Cash | 298 | 41 | 1.516 | 1.956 | 6.358 | 9.619 | 4.034 | 5.791 | 3.344 | 3.770 |
Shareholders Funds | -7.845 | 19.667 | 26.301 | 29.871 | 34.828 | 36.550 | 31.576 | 31.193 | 31.608 | 28.130 |
Social Capital | 45 | 29.291 | 28.993 | 28.502 | 27.979 | 27.437 | 26.917 | 26.320 | 26.402 | 26.322 |
Debts | 35.978 | 8.056 | 6.660 | 1.307 | 825 | 481 | 270 | 40 | 681 | 1.252 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4719 - 4719" | |||||||||
CAEN Financial Year |
4782
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Luxraniva Srl